Abstract
The silent pandemic of antimicrobial resistance (AMR) has been a lethal enemy of mankind for years. Unfortunately, humans have themselves been responsible for the troublesome and worsening trends of AMR. The lack of sanitation and hygiene, lack of awareness among the public, inadequate infection prevention, and control policies in hospitals, indiscriminate antimicrobial use in humans, animals, as well as the environment, and irresponsible disposal of these antibiotics into the environment have made matters worse. Our armamentarium against these pathogens is diminishing gradually with hardly any antibiotics left to treat the patients. Thus, the World Health Organization recently developed the significance pathogen list to rank the development of drugs for the most common but difficult-to-treat pathogens across the world. Carbapenem-unresponsive; Klebsiella spp., Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii, MRSA, and VRE are some of the organisms on the list. Although research is ongoing to discover new molecules to fight these superbugs and cure the infections caused by them, the current pressing main concern is to rectify our practices by following judicious use and proper disposal of antibiotics, working toward the strategic priorities of creating awareness, strictly complying with infection prevention and control protocols along with integration and collaboration among all the sectors (human, animal, environment, research) as identified under the country’s accomplishment strategy on fight against drug-unresponsive superbugs (NAP-AMR) in India.
This is a preview of subscription content, log in via an institution to check access.
References
Ahmed, M. O., & Baptiste, K. E. (2018). Vancomycin-resistant enterococci: A review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microbial Drug Resistance, 24(5), 590–606. https://doi.org/10.1089/mdr.2017.0147
Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/s0140-6736(21)02724-0
Borren, N. Z., Ghadermarzi, S., Hutfless, S., & Ananthakrishnan, A. N. (2017). The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PLoS One, 12(5). https://doi.org/10.1371/journal.pone.0176797
Brown, N. M., Brown, E. M., & the Guideline Development Group. (2021). Treatment of methicillin-resistant Staphylococcus aureus (MRSA): Updated guidelines from the UK. Journal of Antimicrobial Chemotherapy, 76(6), 1377–1378. https://doi.org/10.1093/jac/dkab036
Burnham, C. D., Leeds, J., Nordmann, P., O’Grady, J., & Patel, J. (2017). Diagnosing antimicrobial resistance. Nature Reviews Microbiology, 15(11), 697–703. https://doi.org/10.1038/nrmicro.2017.103
Centers for Disease Control and Prevention. (2018). National antimicrobial resistance monitoring system for enteric bacteria (NARMS): Human isolates surveillance report for 2015 (final report). U.S. Department of Health and Human Services, CDC.
Centers for Disease Control and Prevention. (2019). Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, CDC. https://doi.org/10.15620/cdc:82532
Centers for Disease Control and Prevention. (2021). 2020 national and state healthcare-associated infections progress report. Retrieved 7 Sept 2022, from https://www.cdc.gov/hai/data/portal/progress-report.html
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000). Vancomycin-resistant enterococci. Clinical Microbiology Reviews, 13(4), 686–707. https://doi.org/10.1128/cmr.13.4.686
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017). ACG clinical guideline: Treatment of Helicobacter pylori infection. American Journal of Gastroenterology, 112(2), 212–239. https://doi.org/10.1038/ajg.2016.563
Codjoe, F., & Donkor, E. (2017). Carbapenem resistance: A review. Medical Science, 6(1), 1. https://doi.org/10.3390/medsci6010001
Correa-Martínez, C. L., Jurke, A., Schmitz, J., Schaumburg, F., Kampmeier, S., & Mellmann, A. (2022). Molecular epidemiology of vancomycin-resistant enterococci bloodstream infections in Germany: A population-based prospective longitudinal study. Microorganisms, 10(1), 130. https://doi.org/10.3390/microorganisms10010130
Costa-Lourenço, A. P., Barros dos Santos, K. T., Moreira, B. M., Fracalanzza, S. E., & Bonelli, R. R. (2017). Antimicrobial resistance in Neisseria gonorrhoeae: History, molecular mechanisms and epidemiological aspects of an emerging global threat. Brazilian Journal of Microbiology, 48(4), 617–628. https://doi.org/10.1016/j.bjm.2017.06.001
Cristillo, A. D., Bristow, C. C., Torrone, E., Dillon, J., Kirkcaldy, R. D., Dong, H., et al. (2019). Antimicrobial resistance in Neisseria gonorrhoeae: Proceedings of the Star sexually transmitted infection—Clinical trial group programmatic meeting. Sexually Transmitted Diseases, 46(3). https://doi.org/10.1097/olq.0000000000000929
Crump, J. A., Sjölund-Karlsson, M., Gordon, M. A., & Parry, C. M. (2015). Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections. Clinical Microbiology Reviews, 28(4), 901–937. https://doi.org/10.1128/cmr.00002-15
Cuypers, W. L., Jacobs, J., Wong, V., Klemm, E. J., Deborggraeve, S., & Van Puyvelde, S. (2018). Fluoroquinolone resistance in Salmonella: Insights by whole-genome sequencing. Microbial Genomics, 4(7). https://doi.org/10.1099/mgen.0.000195
Dadgostar, P. (2019). Antimicrobial resistance: Implications and costs. Infection and Drug Resistance, 12, 3903–3910. https://doi.org/10.2147/idr.s234610
Davis, E., Hicks, L., Ali, I., Salzman, E., Wang, J., Snitkin, E., et al. (2020). Epidemiology of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis colonization in nursing facilities. Open Forum Infectious Diseases, 7(1). https://doi.org/10.1093/ofid/ofz553
Dhingra, S., Rahman, N. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., et al. (2020). Microbial resistance movements: An overview of global public health threats posed by antimicrobial resistance, and how best to counter. Frontiers in Public Health, 8. https://doi.org/10.3389/fpubh.2020.535668
Dilnessa, T., Getaneh, A., Hailu, W., Moges, F., & Gelaw, B. (2022). Prevalence and antimicrobial resistance pattern of clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis. PLoS One, 17(1). https://doi.org/10.1371/journal.pone.0262597
Ding, Y., Wang, Y., Hsia, Y., Sharland, M., & Heath, P. T. (2019). Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China. Annals of Clinical Microbiology and Antimicrobials, 18(1), 36.
Doern, G. V., & Brecher, S. M. (2011). The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests. Journal of Clinical Microbiology, 49(9_Supplement). https://doi.org/10.1128/jcm.00580-11
Doi, Y. (2019). Treatment options for carbapenem-resistant gram-negative bacterial infections. Clinical Infectious Diseases, 69(Supplement_7). https://doi.org/10.1093/cid/ciz830
Du, H., Bing, J., Hu, T., Ennis, C. L., Nobile, C. J., & Huang, G. (2020). Candida Auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathogens, 16(10). https://doi.org/10.1371/journal.ppat.1008921
Elshamy, A. A., & Aboshanab, K. M. (2020). A review on bacterial resistance to carbapenems: Epidemiology, detection and treatment options. Future Science OA, 6(3). https://doi.org/10.2144/fsoa-2019-0098
Eng, S., Pusparajah, P., Ab Mutalib, N., Ser, H., Chan, K., & Lee, L. (2015). Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance. Frontiers in Life Science, 8(3), 284–293. https://doi.org/10.1080/21553769.2015.1051243
European Centre for Disease Prevention and Control. (2018). Surveillance of antimicrobial resistance in Europe – Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. ECDC.
European Centre for Disease Prevention and Control. (2020). Antimicrobial consumption in the EU/EEA – Annual epidemiological report 2019. ECDC.
Frías-De-León, M. G., Hernández-Castro, R., Vite-Garín, T., Arenas, R., Bonifaz, A., Castañón-Olivares, L., et al. (2020). Antifungal resistance in Candida auris: Molecular determinants. Antibiotics, 9(9), 568. https://doi.org/10.3390/antibiotics9090568
Garcia-Bustos, V., Cabanero-Navalon, M. D., Ruiz-Saurí, A., Ruiz-Gaitán, A. C., Salavert, M., Tormo, M. Á., & Pemán, J. (2021). What do we know about Candida auris? State of the art, knowledge gaps, and future directions. Microorganisms, 9(10), 2177. https://doi.org/10.3390/microorganisms9102177
Gelband, H. (2016). CARA: The conscience of antimicrobial resistance accountability, and the next big thing for CDDEP [Web log post]. Retrieved 2022, from https://cddep.org/blog/posts/cara_conscience_antimicrobial_resistance_accountability_and_next_big_thing_cddep/
Goderska, K., Agudo Pena, S., & Alarcon, T. (2017). Helicobacter pylori treatment: Antibiotics or probiotics. Applied Microbiology and Biotechnology, 102(1), 1–7. https://doi.org/10.1007/s00253-017-8535-7
Gong, B., Li, H., Feng, Y., Zeng, S., Zhuo, Z., Luo, J., et al. (2022). Prevalence, serotype distribution and antimicrobial resistance of non-typhoidal salmonella in hospitalized patients in Conghua District of Guangzhou, China. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.805384
Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020). Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.00107
Harnvoravongchai, P., Pipatthana, M., Chankhamhaengdecha, S., & Janvilisri, T. (2017). Insights into drug resistance mechanisms in Clostridium difficile. Essays in Biochemistry, 61(1), 81–88. https://doi.org/10.1042/ebc20160062
Hay, S. I., Rao, P. C., Dolecek, C., Day, N. P., Stergachis, A., Lopez, A. D., & Murray, C. J. (2018). Measuring and mapping the global burden of antimicrobial resistance. BMC Medicine, 16(1). https://doi.org/10.1186/s12916-018-1073-z
Hu, Y., Zhu, Y., & Lu, N. (2017). Novel and effective therapeutic regimens for helicobacter pylori in an era of increasing antibiotic resistance. Frontiers in Cellular and Infection Microbiology, 7. https://doi.org/10.3389/fcimb.2017.00168
ICMR. (2019). Indian Council of medical research treatment guidelines for antimicrobial use in common syndromes (2nd ed.). ICMR, Division of ECD, Ansari Nagar.
ICMR (2020). Indian Council of Medical Research Antimicrobial Resistance Research and Surveillance Network (January 2020 to December 2020). Annual report. Division of Epidemiology and Communicable Diseases, ICMR.
Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L. (2019). New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrobial Agents and Chemotherapy, 63(1). https://doi.org/10.1128/aac.01110-18
Jean, S., Harnod, D., & Hsueh, P. (2022). Global threat of carbapenem-resistant gram-negative bacteria. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.823684
Jevons, M. P. (1961). “Celbenin” – Resistant Staphylococci. British Medical Journal, 1(5219), 124–125.
Kaakoush, N. O., Castaño-Rodríguez, N., Mitchell, H. M., & Man, S. M. (2015). Global epidemiology of Campylobacter infection. Clinical Microbiology Reviews, 28(3), 687–720. https://doi.org/10.1128/cmr.00006-15
Kayange, N., Kamugisha, E., Mwizamholya, D. L., Jeremiah, S., & Mshana, S. E. (2010). Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatrics, 10(1). https://doi.org/10.1186/1471-2431-10-39
Khademi, F., & Sahebkar, A. (2020). Prevalence of fluoroquinolone-resistant Campylobacter species in Iran: A systematic review and meta-analysis. International Journal of Microbiology, 2020, 1–14. https://doi.org/10.1155/2020/8868197
Kocsmár, É., Buzás, G. M., Szirtes, I., Kocsmár, I., Kramer, Z., Szijártó, A., et al. (2021). Primary and secondary clarithromycin resistance in helicobacter pylori and mathematical modeling of the role of Macrolides. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-22557-7
Kueakulpattana, N., Wannigama, D. L., Luk-in, S., Hongsing, P., Hurst, C., Badavath, V. N., et al. (2021). Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-00675-y
Lakhundi, S., & Zhang, K. (2018). Methicillin-resistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology. Clinical Microbiology Reviews, 31(4). https://doi.org/10.1128/cmr.00020-18
Laxminarayan, R., Van Boeckel, T., Frost, I., Kariuki, S., Khan, E. A., Limmathurotsakul, D., et al. (2020). The Lancet Infectious Diseases Commission on Antimicrobial Resistance: 6 years later. The Lancet Infectious Diseases, 20(4). https://doi.org/10.1016/s1473-3099(20)30003-7
Leffler, D. A., & Lamont, J. T. (2015). Clostridium difficile infection. New England Journal of Medicine, 372(16), 1539–1548. https://doi.org/10.1056/nejmra1403772
Levitus, M., Rewane, A., & Perera, T. B. (2022). Vancomycin-resistant Enterococci. Stat Pearls Publishing.
Li, J., Song, X., Yang, T., Chen, Y., Gong, Y., Yin, X., & Lu, Z. (2016). A systematic review of antibiotic prescription associated with upper respiratory tract infections in China. Medicine, 95(19). https://doi.org/10.1097/md.0000000000003587
Li, J., Hao, H., Sajid, A., Zhang, H., & Yuan, Z. (2018). Fluoroquinolone resistance in salmonella: Mechanisms, fitness, and virulence. In Salmonella – A re-emerging pathogen. https://doi.org/10.5772/intechopen.74699
Lin, J., Michel, L. O., & Zhang, Q. (2002). CMEABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy, 46(7), 2124–2131. https://doi.org/10.1128/aac.46.7.2124-2131.2002
Losito, A. R., Raffaelli, F., Del Giacomo, P., & Tumbarello, M. (2022). New drugs for the treatment of pseudomonas aeruginosa infections with limited treatment options: A narrative review. Antibiotics, 11(5), 579. https://doi.org/10.3390/antibiotics11050579
Majumder, M. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020). Antimicrobial stewardship: Fighting antimicrobial resistance and protecting Global Public Health. Infection and Drug Resistance, 13, 4713–4738. https://doi.org/10.2147/idr.s290835
Miftahussurur, M., Aftab, H., Shrestha, P. K., Sharma, R. P., Subsomwong, P., Waskito, L. A., et al. (2019). Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics. Antimicrobial Resistance & Infection Control, 8(1). https://doi.org/10.1186/s13756-019-0482-x
Młynarczyk-Bonikowska, B., Majewska, A., Malejczyk, M., Młynarczyk, G., & Majewski, S. (2019). Multiresistant Neisseria gonorrhoeae: A new threat in second decade of the XXI century. Medical Microbiology and Immunology, 209(2), 95–108. https://doi.org/10.1007/s00430-019-00651-4
Modi, C. M., Singh, S. P., Pandya, Y. G., Patel, C. P., & Patel, R. M. (2021). Prevalence of carbapenem-resistant Enterobacteriaceae in a tertiary care hospital of Gujarat, India. Journal of Clinical and Diagnostic Research. https://doi.org/10.7860/jcdr/2021/47332.14627
National Centre for Disease Control. (2016). National treatment guidelines for antimicrobial use in infectious diseases (Version 1.0). NCDC, DGHS, MoHFW, GoI.
National Centre for Disease Control. (2021). (rep.). National Antimicrobial Resistance Surveillance Network (NARS-Net, India). Reporting period January to December 2020. Annual report 2021. NCDC, DGHS, MoHFW, GoI.
National Centre for Disease Control & World Health Organization. (2017). National action plan on antimicrobial resistance (NAP-AMR) 2017–2021 (Rep.). NCDC, MoHFW, GoI.
Nichols, W. W., De Jonge, B. L., Kazmierczak, K. M., Karlowsky, J. A., & Sahm, D. F. (2016). In vitro susceptibility of global surveillance isolates of pseudomonas aeruginosa to ceftazidime-avibactam (inform 2012 to 2014). Antimicrobial Agents and Chemotherapy, 60(8), 4743–4749. https://doi.org/10.1128/aac.00220-16
O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on antimicrobial resistance. Government of the United Kingdom
Peng, Z., Jin, D., Kim, H. B., Stratton, C. W., Wu, B., Tang, Y., & Sun, X. (2017). Update on antimicrobial resistance in clostridium difficile: Resistance mechanisms and antimicrobial susceptibility testing. Journal of Clinical Microbiology, 55(7), 1998–2008. https://doi.org/10.1128/jcm.02250-16
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015). Antimicrobial resistance: A global multifaceted phenomenon. Pathogens and Global Health, 109(7), 309–318. https://doi.org/10.1179/2047773215y.0000000030
Rosales-Reyes, R., Gayosso-Vázquez, C., Fernández-Vázquez, J. L., Jarillo-Quijada, M. D., Rivera-Benítez, C., Santos-Preciado, J. I., & Alcántar-Curiel, M. D. (2017). Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico. PLoS One, 12(8). https://doi.org/10.1371/journal.pone.0182899
Saleem, N., & Howden, C. W. (2020). Update on the management of Helicobacter pylori infection. Current Treatment Options in Gastroenterology, 18(3), 476–487. https://doi.org/10.1007/s11938-020-00300-3
Sheu, C., Chang, Y., Lin, S., Chen, Y., & Hsueh, P. (2019). Infections caused by carbapenem-resistant Enterobacteriaceae: An update on therapeutic options. Frontiers in Microbiology, 10. https://doi.org/10.3389/fmicb.2019.00080
Sholeh, M., Krutova, M., Forouzesh, M., Mironov, S., Sadeghifard, N., Molaeipour, L., et al. (2020). Antimicrobial resistance in Clostridioides (clostridium) difficile derived from humans: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control, 9(1). https://doi.org/10.1186/s13756-020-00815-5
Sierra-Arguello, Y. M., Furian, T. Q., Perdoncini, G., Moraes, H. L. S., Salle, C. T. P., Rodrigues, L. B., dos Santos, L. R., Pereira Gomes, M. J., & do Nascimento, V. P. (2018). Fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli from poultry and human samples assessed by PCR-restriction fragment length polymorphism assay. PLoS One, 13(7). https://doi.org/10.1371/journal.pone.0199974
Sproston, E. L., Wimalarathna, H. M., & Sheppard, S. K. (2018). Trends in fluoroquinolone resistance in campylobacter. Microbial Genomics, 4(8). https://doi.org/10.1099/mgen.0.000198
St. Cyr, S., Barbee, L., Workowski, K. A., Bachmann, L. H., Pham, C., Schlanger, K., et al. (2020). Update to CDC’s treatment guidelines for gonococcal infection, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(50), 1911–1916. https://doi.org/10.15585/mmwr.mm6950a6
Taccone, F. S., Rodriguez-Villalobos, H., De Backer, D., De Moor, V., Deviere, J., Vincent, J., & Jacobs, F. (2006). Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including Tigecycline. European Journal of Clinical Microbiology and Infectious Diseases, 25(4), 257–260. https://doi.org/10.1007/s10096-006-0123-1
Taneja, N., & Sharma, M. (2019). Antimicrobial resistance in the environment: The Indian scenario. Indian Journal of Medical Research, 149(2), 119. https://doi.org/10.4103/ijmr.ijmr_331_18
Teo, J. Q.-M., Lim, J. C., Tang, C. Y., Lee, S. J.-Y., Tan, S. H., Sim, J. H.-C., Ong, R. T.-H., & Kwa, A. L.-H. (2021). Ceftolozane/tazobactam resistance and mechanisms in carbapenem-non susceptible Pseudomonas aeruginosa. mSphere, 6(1). https://doi.org/10.1128/msphere.01026-20
Turner, N. A., & Anderson, D. J. (2020). Hospital infection control: Clostridiodes difficile. Clinics in Colon and Rectal Surgery, 33(02), 098–108. https://doi.org/10.1055/s-0040-1701234
Unemo, M., Lahra, M. M., Escher, M., Eremin, S., Cole, M. J., Galarza, P., Ndowa, F., Martin, I., Dillon, J. R., Galas, M., Ramon-Pardo, P., Weinstock, H., & Wi, T. (2021). Who global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: A retrospective observational study. The Lancet Microbe, 2(11). https://doi.org/10.1016/s2666-5247(21)00171-3
Vasala, A., Hytönen, V. P., & Laitinen, O. H. (2020). Modern tools for rapid diagnostics of antimicrobial resistance. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.00308
Veeraraghavan, B., Pragasam, A. K., Ray, P., Kapil, A., Nagaraj, S., Perumal, S. P., et al. (2021). Evaluation of antimicrobial susceptibility profile in Salmonella typhi and Salmonella paratyphi A: Presenting the current scenario in India and strategy for future management. The Journal of Infectious Diseases, 224(Supplement_5). https://doi.org/10.1093/infdis/jiab144
Vercelli, C., Gambino, G., Amadori, M., & Re, G. (2022). Implications of veterinary medicine in the comprehension and stewardship of antimicrobial resistance phenomenon. From the origin till nowadays. Veterinary and Animal Science, 16, 100249. https://doi.org/10.1016/j.vas.2022.100249
Viehman, J. A., Nguyen, M. H., & Doi, Y. (2014). Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs, 74(12), 1315–1333. https://doi.org/10.1007/s40265-014-0267-8
Whelan, M. V., Ardill, L., Koide, K., Nakajima, C., Suzuki, Y., Simpson, J. C., & Cróinín, Ó. T. (2019). Acquisition of fluoroquinolone resistance leads to increased biofilm formation and pathogenicity in campylobacter jejuni. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-54620-1
Wieczorek, K., & Osek, J. (2013). Antimicrobial resistance mechanisms among campylobacter. BioMed Research International, 2013, 1–12. https://doi.org/10.1155/2013/340605
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017). Clinical and pathophysiological overview of Acinetobacter infections: A century of challenges. Clinical Microbiology Reviews, 30(1), 409–447. https://doi.org/10.1128/cmr.00058-16
World Health Organization. (2014). WHO’s first global report on antibiotic resistance reveals serious, worldwide threat to public health. News release. WHO. Available on https://www.who.int/southeastasia/news/detail/30-04-2014-who-s-first-global-report-on-antibiotic-resistance-reveals-serious-worldwide-threat-to-public-health
World Health Organization. (2017). WHO publishes list of bacteria for which new antibiotics are urgently needed. News Release. WHO. Available on https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
Xu, C., Wang, D., Zhang, X., Liu, H., Zhu, G., Wang, T., et al. (2020). Mechanisms for rapid evolution of carbapenem resistance in a clinical isolate of Pseudomonas aeruginosa. Frontiers in Microbiology, 11. https://doi.org/10.3389/fmicb.2020.01390
Acknowledgments
The authors thank Moe Moore, Reeti Hobson, Ashima Jain Vidyarthi, Shreeparna Ghosh, and Rajesh Bhatia for their efforts in providing an insightful review and inputs to refine the chapter.
Disclaimer
This chapter was created with funding from the USAID, Global Health, under the terms of the Infectious Disease Detection and Surveillance contract GS00Q14OADU119. Opinions stated are not essentially those of USAID or the US government.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Saini, S., Thass, N., Kayesth, J., Sikhondze, W. (2023). Antimicrobial Resistance Associated with Infectious Diseases. In: Mothadaka, M.P., Vaiyapuri, M., Rao Badireddy, M., Nagarajrao Ravishankar, C., Bhatia, R., Jena, J. (eds) Handbook on Antimicrobial Resistance. Springer, Singapore. https://doi.org/10.1007/978-981-16-9723-4_49-1
Download citation
DOI: https://doi.org/10.1007/978-981-16-9723-4_49-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-9723-4
Online ISBN: 978-981-16-9723-4
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences